Our current results indicate that vaccination against PAMP results in a significant decrease in the number of Ki67+ (proliferating) melanoma cells, pointing to a direct role of PAMP as a growth factor for this cancer of the skin. This evidence concerns the gene MKI67 and skin neoplasm.